State Street Corporation 13D and 13G filings for PMV Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-23 09:07 am Purchase | 2023-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP | STATE STREET CORP STT | 723,454 1.410% | 76,904 (+11.89%) | Filing |
| 2023-05-10 09:19 am Sale | 2023-04-30 | 13G | PMV Pharmaceuticals, Inc. PMVP | STATE STREET CORP STT | 646,550 1.410% | -2,660,686 (-80.45%) | Filing |
| 2023-02-10 11:26 am Sale | 2022-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP | STATE STREET CORP STT | 3,307,236 7.240% | -1,864,254 (-36.05%) | Filing |
| 2022-07-11 1:28 pm Purchase | 2022-06-30 | 13G | PMV Pharmaceuticals, Inc. PMVP | STATE STREET CORP STT | 5,171,490 11.350% | 5,171,490 (New Position) | Filing |